Carnexiv WTF

This product was born with broken legs. I do not think it will ever come to market. People start looking for a new job. We really only have one secure drug to sell, that is Onfi. Northera born with one broken leg lips along.. Thoughts?

 

You are correct. Unless we go out and buy some more stuff to sell, this whole company is toast once Onfi LOE hits.

 

Carnexiv sales will peak at 30 million per year.

That's Trintellix level bad!

 

we paid off a few billion in debt this year early, will be interesting to see how much financial accounting will be put into buying new products using cash to buy products that can drive future growth.

CEO Kare telling us about the stock price is laughable... since when do US based employees get to be a piece of the company. We are just little people that they lean on to drive the global portfolio. Seems we are driving a bus in the fog up the mountain.

 

Buying a drug with any upside that is near approval costs at least a billion these days. Then you have companies throwing 10-20 billion around to gain access to single assets that have blockbuster potential.

They don't have much time if they don't want to lose their specialty neuro sales force.

 

What are the chances that we even launch this drug? It has been doomed since the beginning

 

I wouldn't be surprised if major changes happen before LUNA.

Pray for us.... Happy Holidays Everest Team.

 

$30 million a year will be amazing for this drug! No, 2017 will usher in major changes. My bet is that there will be 1 psych force selling a mix of AM,Trin and Rex. Anybody's guess about what's in store for neuro. Putting gamma and beta together positions that group for a downsizing for sure. Keep the best, fire the rest.

Hell, we may even have ONE sales force with a different mix of neuro and psych drugs! Who knows?

 

Starting in 2018 there are only 2 options for the next ~5 years.

1. Limp onward with only the psych products we have, or

2. Buy some neuro products to sell. (In my opinion it was foolish to dissolve our orphan epilepsy infrastructure as that was the most fertile in licensing space).

Either way, Lundbeck is going to be smaller and cash strapped moving forward. Take your 2017 bonus and move on while you can.

 

Why, what's wrong with it?

 

Is it true that two of the Northera Marketing team left today?

Is Neuro going to die soon...

This is craziness....

 

What! Who?

 

JG & the new guy that hasn't been here for longer than a hot minute...

 

No loss with JG, she had zero Pharma experience and she's responsible for running off Katie Moser. Bill wasn't here long enough to know if he's a good or bad loss but I would hardly be worried with either of them leaving.

 

Bill came here to launch idalopirdine. Once it was clear that drug will never launch he had no reason to stay.

 

Can't blame them. Having to deal with that no talent product director would make anyone want out.

 

I'm confused. Who and why "no talent."

 

JG as in Jessie Goldmember?

 

That's the one, and she was by far the least talented out of the Northera marketing team. Not sure if she quit or was asked to leave but either way they surely can do better

 

I agree. You bottom feeding sales reps with just a high school education could do worlds better!